Gene expression profiling of tamoxifen-associated uterine cancers: evidence for two molecular classes of endometrial carcinoma

This publication has 13 references indexed in Scilit:

• Molecular determinants of tumor differentiation in papillary serous ovarian carcinoma
  Molecular Carcinogenesis, 2003
• Cancer Statistics, 2003
  CA: A Cancer Journal for Clinicians, 2003
• The secrets of selective estrogen receptor modulation: Cell-specific coregulation
  Cancer Cell, 2002
• Relationship between expression of genes involved in cell cycle control and apoptosis in diffuse large B cell lymphoma: a preferential survivin–cyclin B link
  Leukemia, 2002
• Risk and prognosis of endometrial cancer after tamoxifen for breast cancer
  The Lancet, 2000
• Chapter 3: Endogenous Estrogens as Carcinogens Through Metabolic Activation
  JNCI Monographs, 2000
• Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
  JNCI Journal of the National Cancer Institute, 1998
• Tamoxifen Use in Breast Cancer Patients Who Subsequently Develop Corpus Cancer Is Not Associated with a Higher Incidence of Adverse Histologic Features
  Gynecologic Oncology, 1994
• Endometrial Cancer in Tamoxifen-Treated Breast Cancer Patients: Findings From the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14 *
  JNCI Journal of the National Cancer Institute, 1994
• The epidemiology of endometrial cancer
  Gynecologic Oncology, 1991